SiSaf Enabled Alopecia Areata Topical Treatment Trial Success
10 Jun 2024 //
GLOBENEWSWIRE
Publication of Positive Preclinical Data of SiSaf`s SIS-ADO2 Program
18 Sep 2023 //
GLOBENEWSWIRE
SiSaf Appoints Nikos Tzagkarakis in the New Role of Chief A.I. Officer
13 Jul 2023 //
GLOBENEWSWIRE
FDA Grants SiSafs Innovative siRNA Therapy SIS-101-ADO Orphan Drug Designation
15 May 2023 //
GLOBENEWSWIRE
SiSaf Appoints Dr. Richard Goodfellow to Board of Directors
05 Apr 2023 //
GLOBENEWSWIRE
SiSaf & the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA
02 Mar 2023 //
GLOBENEWSWIRE